個股熱度排行 | 2月4日港股盤前
根據uSMART輿情監測數據，從3日晚間到4日港股盤前時間段，市場關注指數最高的5只股票是京東集團-SW、比亞迪股份、理想汽車-W、信達生物、百濟神州。
2月4日—港股關注排行TOP5
京東集團-SW
關注度第一爲京東集團-SW，該股上個交易日收盤上漲5.11%，報於279.60港元。近5個交易日累計下跌3.32%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
京東：春晚期間全球華人蔘與京東APP紅包累計互動量達691億
京東集團-SW：董事會主席兼首席執行官將捐贈6237.6643萬股B類普通股作慈善用途
比亞迪股份
關注度第二爲比亞迪股份，該股上個交易日收盤上漲0.73%，報於221.40港元。近5個交易日累計下跌12.21%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
比亞迪股份1月新能源汽車銷量9.32萬輛 同比增361.73%
比亞迪股份1月新能源汽車銷量9.32萬輛 同比增361.73%
理想汽車-W
關注度第三爲理想汽車-W，該股上個交易日收盤上漲1.68%，報於93.80港元。近5個交易日累計下跌14.73%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
理想汽車1月交付1.2萬輛理想ONE 同比增長128.1%
理想汽車-W：1月交付1.23萬輛理想ONE，同比增長128.1%
信達生物
關注度第四爲信達生物，該股上個交易日收盤上漲6.34%，報於32.70港元。近5個交易日累計下跌20.92%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
信達生物：信迪利單抗注射液第四季度票面銷售收入9億元
信達生物：達伯舒®第四季度銷售收入達9億元，銷量保持逐季增長良好態勢
百濟神州
關注度第五爲百濟神州，該股上個交易日收盤上漲7.17%，報於128.60港元。近5個交易日累計下跌13.34%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
百濟神州因受限制股份單位獲歸屬發行35.22萬股
百濟神州委任Alessandro Riva等爲獨立非執行董事
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
